HKMPY

Healthcare Drug Manufacturers - Specialty & Generic

Hikma Pharmaceuticals PLC

$42.50

-0.50 -1.16% today

Price History

Not enough data

Key Stats

Market Cap

4.40B

Avg Volume

410

P/E (TTM)

12.07

EPS

$3.52

52W High

$49.86

52W Low

$31.80

Div. Yield

2.0%

Valuation

P/B Ratio

1.82

P/S Ratio

1.29

EV/EBITDA

7.15

EV/Revenue

1.84

PEG Ratio

1.74

Margins

Gross Margin 44.0%

Operating Margin 23.5%

Net Margin 11.3%

EBITDA Margin 25.7%

Growth & Returns

Revenue Growth (YoY)

4.2%

Earnings Growth (YoY)

(4.7%)

Earnings Growth (QoQ)

(6.3%)

Return on Equity

15.4%

Return on Assets

7.5%

Liquidity & Leverage

Current Ratio

1.98

Quick Ratio

1.02

Debt / Equity

0.77

Total Cash

289.00M

Total Debt

1.96B

About

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products. The company operates through three segments: Injectables, Hikma Rx, and Branded. The Injectables segment provides generic and specialty injectable products primarily for use in hospitals. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The Hikma Rx segment offers oral, respiratory, and other generic and specialty products for the retail market. It provides its products in various therapeutic areas, including respiratory, oncology, and pain management. The company also offers its products in solid, semi-solid, liquid, and injectable dosage forms. It operates in the United Kingdom, Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, United Kingdom.